TerrAscend (TSNDF) Other Non Operating Income (2021 - 2026)
TerrAscend (TSNDF) posted quarterly Other Non Operating Income of $428000.0 for Q1 2026, up 1119.05% year-over-year from $35109.4 in Q1 2025, and down 81.55% quarter-over-quarter from $2.3 million in Q4 2025.
TerrAscend (TSNDF) Other Non Operating Income (2021 - 2026) Analysis & Trends
TerrAscend (TSNDF) has reported Other Non Operating Income for 6 consecutive years, with $428000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Non Operating Income rose 1119.05% year-over-year to $428000.0; the TTM figure through Mar 2026 stood at $3.7 million (up 80.03% YoY), while the FY2025 annual figure was $888000.0, down 81.69% from the prior year.
- Other Non Operating Income eased to $428000.0 in Q1 2026 per TSNDF's latest filing, from $2.3 million in the prior quarter.
- Across five years, Other Non Operating Income topped out at $4.3 million in Q4 2024 and bottomed at -$2.1 million in Q3 2024.
- Historically, Other Non Operating Income has averaged $172705.9 across 5 years, with a median of -$42000.0 in 2025.
- Annual changes were most pronounced in 2022 — Other Non Operating Income plunged 3786.67% — and 2024, when it soared 2551.43%.
- TerrAscend's Other Non Operating Income stood at -$881000.0 in 2022, then jumped by 80.14% to -$175000.0 in 2023, then jumped by 2551.43% to $4.3 million in 2024, then tumbled by 45.92% to $2.3 million in 2025, then slumped by 81.55% to $428000.0 in 2026.
- Business Quant data shows TSNDF's Other Non Operating Income at $428000.0 in Q1 2026, $2.3 million in Q4 2025, and $291000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.86 Bn | 42.90 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.54 Bn | 2.15 Bn |
| 3 | Zoetis | 31.46 Bn | 29.79 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.57 Bn | 22.77 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.71 Bn | 11.18 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | TerrAscend | 187.35 Mn | 145.23 Mn | 36.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 537,000.00 |
| Mar 31, 2026 | 428,000.00 |
| Dec 31, 2025 | 2.32 Mn |
| Sep 30, 2025 | 291,000.00 |
| Jun 30, 2025 | 648,000.00 |
| Mar 31, 2025 | -42,000.00 |
| Dec 31, 2024 | 4.29 Mn |
| Sep 30, 2024 | -2.10 Mn |
| Jun 30, 2024 | -104,000.00 |
| Mar 31, 2024 | -285,000.00 |
| Dec 31, 2023 | -175,000.00 |
| Sep 30, 2023 | -120,000.00 |
| Jun 30, 2023 | 101,000.00 |
| Mar 31, 2023 | 23,000.00 |
| Dec 31, 2022 | -881,000.00 |
| Sep 30, 2022 | -583,000.00 |
| Jun 30, 2022 | -1.15 Mn |
| Mar 31, 2022 | 271,000.00 |
| Dec 31, 2021 | 4.81 Mn |
| Sep 30, 2021 | -15,000.00 |